BioTelemetry

$53.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.85 (+1.60%) Today
$0.00 (0.00%) As of 1:13 PM EST after-hours

Why Robinhood?

You can buy or sell BioTelemetry and other stocks, options, and ETFs commission-free!

About BEAT

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA. The listed name for BEAT is BioTelemetry, Inc. Common Stock.

CEO
Joseph H. Capper
Employees
1,700
Headquarters
Malvern, Pennsylvania
Founded
2013
Market Cap
1.85B
Price-Earnings Ratio
111.75
Dividend Yield
Average Volume
273.82K
High Today
$54.06
Low Today
$52.68
Open Price
$53.25
Volume
123.67K
52 Week High
$55.85
52 Week Low
$27.35

Collections

BEAT Earnings

$0.00
$0.18
$0.35
$0.53
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, After Hours

You May Also Like